Variant report
Variant | rs1211088 |
---|---|
Chromosome Location | chr21:46016170-46016171 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ESR1 | chr21:46016036-46016511 | ECC-1 | luminal epithelium: | n/a | n/a |
2 | NR3C1 | chr21:46015992-46016492 | ECC-1 | luminal epithelium: | n/a | n/a |
3 | NFIC | chr21:46015984-46016723 | ECC-1 | luminal epithelium: | n/a | n/a |
4 | TEAD4 | chr21:46016105-46016610 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | ESR1 | chr21:46016113-46016556 | ECC-1 | luminal epithelium: | n/a | n/a |
6 | NFIC | chr21:46016004-46016672 | ECC-1 | luminal epithelium: | n/a | n/a |
7 | MYC | chr21:46015844-46016378 | K562 | blood: | n/a | n/a |
8 | TCF12 | chr21:46016109-46016690 | ECC-1 | luminal epithelium: | n/a | n/a |
9 | MAX | chr21:46015946-46016612 | ECC-1 | luminal epithelium: | n/a | n/a |
10 | MAX | chr21:46015931-46016517 | ECC-1 | luminal epithelium: | n/a | n/a |
11 | CTCF | chr21:46016160-46016310 | HMEC | breast: | n/a | n/a |
12 | FOXM1 | chr21:46016078-46016800 | ECC-1 | luminal epithelium: | n/a | n/a |
13 | ZNF263 | chr21:46016099-46016348 | HEK293-T-REx | kidney: | n/a | n/a |
14 | NR3C1 | chr21:46015947-46016526 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | ESR1 | chr21:46016116-46016535 | ECC-1 | luminal epithelium: | n/a | n/a |
16 | TCF12 | chr21:46016002-46016659 | ECC-1 | luminal epithelium: | n/a | n/a |
17 | EP300 | chr21:46016049-46016748 | ECC-1 | luminal epithelium: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:45997782..46000332-chr21:46014593..46016862,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256212 | TF binding region |
KRTAP10-7 | TF binding region |
KRTAP10-6 | TF binding region |
rs_ID | r2[population] |
---|---|
rs116344 | 0.82[EUR][1000 genomes] |
rs1211061 | 0.87[CHB][hapmap] |
rs1211089 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1211103 | 1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs1211118 | 0.84[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1211121 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.86[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1211122 | 0.86[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs1211123 | 0.93[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1211129 | 0.84[EUR][1000 genomes] |
rs1211130 | 0.84[EUR][1000 genomes] |
rs12627104 | 0.93[ASN][1000 genomes] |
rs12627414 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.88[ASN][1000 genomes] |
rs170849 | 0.82[MEX][hapmap] |
rs2226687 | 0.82[MEX][hapmap] |
rs233298 | 0.87[ASN][1000 genomes] |
rs233299 | 0.87[ASN][1000 genomes] |
rs233300 | 0.91[ASN][1000 genomes] |
rs2838598 | 0.94[CHB][hapmap];1.00[MEX][hapmap] |
rs366534 | 0.87[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs367771 | 0.81[CHB][hapmap] |
rs369111 | 0.85[CHB][hapmap] |
rs369720 | 0.84[ASN][1000 genomes] |
rs370092 | 0.94[CHB][hapmap];1.00[JPT][hapmap];0.92[TSI][hapmap];0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs371248 | 1.00[CHB][hapmap];1.00[JPT][hapmap] |
rs377234 | 1.00[CHB][hapmap];0.86[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs377263 | 0.81[GIH][hapmap];1.00[TSI][hapmap] |
rs377573 | 0.83[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs379858 | 0.87[CHB][hapmap] |
rs382935 | 1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs384645 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs385033 | 0.93[ASN][1000 genomes] |
rs389936 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs390630 | 0.95[EUR][1000 genomes] |
rs392451 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs392686 | 0.94[CHB][hapmap];0.88[GIH][hapmap];1.00[MEX][hapmap];0.91[TSI][hapmap];0.85[EUR][1000 genomes] |
rs395781 | 0.84[EUR][1000 genomes] |
rs398680 | 1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs400170 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs400368 | 0.87[CHB][hapmap] |
rs400406 | 1.00[CEU][hapmap];0.84[JPT][hapmap];0.95[EUR][1000 genomes] |
rs403981 | 0.83[ASW][hapmap];1.00[CHB][hapmap];0.87[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.83[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs404341 | 1.00[CHB][hapmap];0.87[CHD][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs408183 | 0.80[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs408285 | 0.91[AFR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs408516 | 0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs408958 | 0.94[CHB][hapmap];0.84[EUR][1000 genomes] |
rs409239 | 0.84[EUR][1000 genomes] |
rs409893 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs411254 | 0.86[JPT][hapmap];0.82[MEX][hapmap] |
rs415753 | 0.94[CHB][hapmap];0.85[GIH][hapmap];0.83[TSI][hapmap];0.85[EUR][1000 genomes] |
rs416056 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[AMR][1000 genomes];0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs417538 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[AMR][1000 genomes];0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs418260 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.92[GIH][hapmap];1.00[JPT][hapmap];0.82[MEX][hapmap];0.82[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs425276 | 0.84[EUR][1000 genomes] |
rs430609 | 0.87[CHB][hapmap] |
rs434716 | 0.87[CHB][hapmap] |
rs437149 | 0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs437371 | 0.84[EUR][1000 genomes] |
rs438444 | 1.00[CEU][hapmap];0.95[EUR][1000 genomes] |
rs442110 | 0.86[ASN][1000 genomes] |
rs442226 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs442761 | 0.91[AFR][1000 genomes];0.86[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs442849 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs443484 | 0.95[EUR][1000 genomes] |
rs445214 | 0.86[JPT][hapmap] |
rs446817 | 0.86[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs447568 | 0.83[ASN][1000 genomes] |
rs452002 | 1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs452547 | 0.88[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs455413 | 0.87[CHB][hapmap] |
rs455562 | 0.87[CHB][hapmap] |
rs455714 | 0.87[CHB][hapmap] |
rs455777 | 0.87[CHB][hapmap] |
rs455906 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs456444 | 0.87[CHB][hapmap] |
rs457322 | 0.87[CHB][hapmap] |
rs459644 | 1.00[CEU][hapmap];1.00[GIH][hapmap];1.00[TSI][hapmap];0.95[EUR][1000 genomes] |
rs459845 | 0.87[CHB][hapmap] |
rs459915 | 0.87[CHB][hapmap] |
rs460064 | 0.87[CHB][hapmap] |
rs460085 | 0.87[CHB][hapmap] |
rs460122 | 0.87[CHB][hapmap] |
rs462254 | 0.87[CHB][hapmap] |
rs463239 | 0.87[CHB][hapmap] |
rs463267 | 0.87[CHB][hapmap] |
rs463668 | 0.87[CHB][hapmap] |
rs463876 | 0.92[EUR][1000 genomes] |
rs464281 | 0.87[CHB][hapmap] |
rs464504 | 0.87[CHB][hapmap] |
rs464684 | 0.87[CHB][hapmap] |
rs465930 | 0.87[CHB][hapmap] |
rs466094 | 0.87[CHB][hapmap] |
rs466628 | 0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs487102 | 0.82[MEX][hapmap] |
rs56274513 | 0.89[ASN][1000 genomes] |
rs58029281 | 0.81[ASN][1000 genomes] |
rs58757665 | 0.97[ASN][1000 genomes] |
rs659638 | 1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap];0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv33817 | chr21:45169412-46031810 | Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 121 gene(s) | inside rSNPs | diseases |
2 | nsv913943 | chr21:45740823-46031810 | Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Strong transcription Weak transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 52 gene(s) | inside rSNPs | diseases |
3 | nsv913946 | chr21:45838632-46031810 | Bivalent Enhancer ZNF genes & repeats Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
4 | nsv913948 | chr21:45860912-46031810 | Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 29 gene(s) | inside rSNPs | diseases |
5 | nsv1056424 | chr21:45894901-46031810 | Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
6 | nsv544475 | chr21:45894901-46031810 | Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Weak transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
7 | nsv1055163 | chr21:45895663-46031810 | Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
8 | nsv1065798 | chr21:45941000-46097463 | Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
9 | nsv869108 | chr21:45941000-46097463 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
10 | nsv544476 | chr21:45941000-46097463 | Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
11 | nsv913950 | chr21:45985068-46097463 | Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
12 | nsv913952 | chr21:45988426-46031810 | Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
13 | esv2751931 | chr21:45990446-46031810 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
14 | nsv587810 | chr21:45992131-46031810 | Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
15 | nsv916258 | chr21:45995986-46624705 | Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 102 gene(s) | inside rSNPs | diseases |
16 | nsv913953 | chr21:46012524-46031810 | ZNF genes & repeats Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Genic enhancers | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46002400-46018200 | Weak transcription | Right Atrium | heart |
2 | chr21:46014000-46017600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr21:46014000-46018000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr21:46014200-46017600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr21:46014200-46017800 | Weak transcription | NHEK | skin |
6 | chr21:46014200-46018200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr21:46014200-46021400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr21:46014400-46016200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr21:46014400-46017600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr21:46014400-46017600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr21:46014600-46017600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
12 | chr21:46014600-46021600 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr21:46015400-46016400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr21:46016000-46016200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr21:46016000-46016400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr21:46016000-46016600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr21:46016000-46016800 | Enhancers | HMEC | breast |